Literature DB >> 7787596

Occurrence of different cancers in patients with Parkinson's disease.

H Møller1, L Mellemkjaer, J K McLaughlin, J H Olsen.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7787596      PMCID: PMC2549877          DOI: 10.1136/bmj.310.6993.1500

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Low cancer rates among patients with Parkinson's disease.

Authors:  B Jansson; J Jankovic
Journal:  Ann Neurol       Date:  1985-05       Impact factor: 10.422

2.  Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.

Authors:  M M Wick; E Frei
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

3.  Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.

Authors:  A S Kochar
Journal:  Am J Med       Date:  1985-07       Impact factor: 4.965

4.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.

Authors:  A Grandinetti; D M Morens; D Reed; D MacEachern
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

  4 in total
  25 in total

1.  Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.

Authors:  Kathrine Rugbjerg; Søren Friis; Christina Funch Lassen; Beate Ritz; Jørgen H Olsen
Journal:  Int J Cancer       Date:  2012-03-22       Impact factor: 7.396

2.  A recurrent mutation in PARK2 is associated with familial lung cancer.

Authors:  Donghai Xiong; Yian Wang; Elena Kupert; Claire Simpson; Susan M Pinney; Colette R Gaba; Diptasri Mandal; Ann G Schwartz; Ping Yang; Mariza de Andrade; Claudio Pikielny; Jinyoung Byun; Yafang Li; Dwight Stambolian; Margaret R Spitz; Yanhong Liu; Christopher I Amos; Joan E Bailey-Wilson; Marshall Anderson; Ming You
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

Review 3.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 4.  Meta-analysis of the relationship between Parkinson disease and melanoma.

Authors:  Rui Liu; Xiang Gao; Yi Lu; Honglei Chen
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

Review 5.  Parkin and mitophagy in cancer.

Authors:  J P Bernardini; M Lazarou; G Dewson
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

6.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

Review 7.  The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.

Authors:  Rivka Inzelberg; Simon D Israeli-Korn
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

8.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.

Authors:  Paul A Northcott; David J H Shih; John Peacock; Livia Garzia; A Sorana Morrissy; Thomas Zichner; Adrian M Stütz; Andrey Korshunov; Jüri Reimand; Steven E Schumacher; Rameen Beroukhim; David W Ellison; Christian R Marshall; Anath C Lionel; Stephen Mack; Adrian Dubuc; Yuan Yao; Vijay Ramaswamy; Betty Luu; Adi Rolider; Florence M G Cavalli; Xin Wang; Marc Remke; Xiaochong Wu; Readman Y B Chiu; Andy Chu; Eric Chuah; Richard D Corbett; Gemma R Hoad; Shaun D Jackman; Yisu Li; Allan Lo; Karen L Mungall; Ka Ming Nip; Jenny Q Qian; Anthony G J Raymond; Nina T Thiessen; Richard J Varhol; Inanc Birol; Richard A Moore; Andrew J Mungall; Robert Holt; Daisuke Kawauchi; Martine F Roussel; Marcel Kool; David T W Jones; Hendrick Witt; Africa Fernandez-L; Anna M Kenney; Robert J Wechsler-Reya; Peter Dirks; Tzvi Aviv; Wieslawa A Grajkowska; Marta Perek-Polnik; Christine C Haberler; Olivier Delattre; Stéphanie S Reynaud; François F Doz; Sarah S Pernet-Fattet; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Wolfram Scheurlen; Charles G Eberhart; Michelle Fèvre-Montange; Anne Jouvet; Ian F Pollack; Xing Fan; Karin M Muraszko; G Yancey Gillespie; Concezio Di Rocco; Luca Massimi; Erna M C Michiels; Nanne K Kloosterhof; Pim J French; Johan M Kros; James M Olson; Richard G Ellenbogen; Karel Zitterbart; Leos Kren; Reid C Thompson; Michael K Cooper; Boleslaw Lach; Roger E McLendon; Darell D Bigner; Adam Fontebasso; Steffen Albrecht; Nada Jabado; Janet C Lindsey; Simon Bailey; Nalin Gupta; William A Weiss; László Bognár; Almos Klekner; Timothy E Van Meter; Toshihiro Kumabe; Teiji Tominaga; Samer K Elbabaa; Jeffrey R Leonard; Joshua B Rubin; Linda M Liau; Erwin G Van Meir; Maryam Fouladi; Hideo Nakamura; Giuseppe Cinalli; Miklós Garami; Peter Hauser; Ali G Saad; Achille Iolascon; Shin Jung; Carlos G Carlotti; Rajeev Vibhakar; Young Shin Ra; Shenandoah Robinson; Massimo Zollo; Claudia C Faria; Jennifer A Chan; Michael L Levy; Poul H B Sorensen; Matthew Meyerson; Scott L Pomeroy; Yoon-Jae Cho; Gary D Bader; Uri Tabori; Cynthia E Hawkins; Eric Bouffet; Stephen W Scherer; James T Rutka; David Malkin; Steven C Clifford; Steven J M Jones; Jan O Korbel; Stefan M Pfister; Marco A Marra; Michael D Taylor
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

Review 9.  Rasagiline: a review of its use in the management of Parkinson's disease.

Authors:  Vicki Oldfield; Gillian M Keating; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Cancer in Parkinson's disease.

Authors:  Pawel Tacik; Sadie Curry; Shinsuke Fujioka; Audrey Strongosky; Ryan J Uitti; Jay A van Gerpen; Nancy N Diehl; Michael G Heckman; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2016-06-20       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.